BIO-RAD LABORATORIES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 286.1 USD | -0.39% |
|
-1.16% | -11.40% |
Presenter SpeechConor Noel McNamara (Analysts)Everyone, welcome to RBC Capital Markets 2024 Gl...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Bio-Rad Laboratories, Inc. is specialized in the development, manufacturing and marketing of products used in life sciences research, clinical diagnostics and analytical chemistry. Net sales break down by activity as follows:
- manufacture of clinical diagnostic tests and automated test systems (51.8%). The group also offers test kits, quality control systems and related IT systems;
- manufacture of reagents, equipment and instruments for biological research (48.1%): for the separation, identification and purification of chemical and biological substances (proteins, nucleic acids, bacteria, etc.) for the proteomics, genomics research, biopharmaceuticals, cell biology and food safety markets;
- other (0.1%): in particular, manufacturing of analytical instruments.
At the end of 2022, the Group has 16 production sites in the United States (5), Germany (3), France (2), China (2), Poland, the United Kingdom, Switzerland and Singapore.
Net sales are distributed geographically as follows: the United States (41.2%), Europe (30.4%), Asia (22.8%) and other (5.6%).
Calendar
2024-06-06
- Jefferies Global Healthcare Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
286.1
USD
Average target price
393.8
USD
Spread / Average Target
+37.65%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -11.40% | 8.13B | |
| -7.38% | 177B | |
| -0.46% | 108B | |
| -6.98% | 65.55B | |
| +2.65% | 50.66B | |
| +5.27% | 42.58B | |
| +6.01% | 40.74B | |
| +19.92% | 31.07B | |
| +16.27% | 25.45B | |
| -7.00% | 23.85B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- Transcript : Bio-Rad Laboratories, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 02
